Significant Accounting Policies (Policies) | 12 Months Ended |
Jun. 30, 2021 |
Accounting Policies [Abstract] | |
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block] | Subsidiaries On January 22, 1999, September 1999, |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation The consolidated financial statements include the accounts of Natural Alternatives International, Inc. (NAI) and our wholly-owned subsidiary, NAIE. All intercompany accounts and transactions have been eliminated. The functional currency of NAIE, our foreign subsidiary, is the U.S. Dollar. Certain accounts of NAIE have been translated at either current or historical exchange rates, as appropriate, with gains and losses included in the consolidated statements of operations. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Adopted Accounting Pronouncements We did not June 30, 2021. Recently Issued Accounting Pronouncements On December 18, 2019, No. 2019 12, Income Taxes (Topic 740 740 December 15, 2020, first 2022. not In March 2020, 2020 04, 848 no December 1, 2022 ( 2023 not |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents We consider all highly liquid investments with a maturity of three |
Fair Value Measurement, Policy [Policy Text Block] | Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We use a three The fair value hierarchy is broken down into three 1 1 2 not 3 Except for cash and cash equivalents, as of June 30, 2021 June 30, 2020, not 1. 2 June 30, 2021 $0.8 June 30, 2020 $0.3 third 2 June 30, 2021 June 30, 2020, not 3. not 2021. |
Accounts Receivable [Policy Text Block] | Accounts Receivable We perform ongoing credit evaluations of our customers and adjust credit limits based on payment history and customer credit-worthiness. An allowance for estimated doubtful accounts is maintained based on historical experience, including identified customer credit issues. We monitor collections regularly and adjust the allowance for doubtful accounts as necessary to recognize any changes in credit exposure. Upon conclusion that a receivable is uncollectible, we record the respective amount as a charge against allowance for doubtful accounts. To date, such doubtful accounts reserves, in the aggregate, have been adequate to cover collection losses. |
Financing Receivable [Policy Text Block] | Customer Deposits For certain customers we have contract terms where the customer pays a certain portion of their orders as prepayment. We treat this as a customer deposit liability and do not June 30, 2021 $1.7 June 30, 2020 $0.1 |
Inventory, Policy [Policy Text Block] | Inventories We operate primarily as a private-label contract manufacturer. We build products based upon anticipated demand or following receipt of customer specific purchase orders. From time to time, we build inventory for private-label contract manufacturing customers under a specific purchase order with delivery dates that may first first not |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment We state property and equipment at cost. Depreciation of property and equipment is provided using the straight-line method over their estimated useful lives, generally ranging from 1 39 |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Impairment of Long-Lived Assets We periodically evaluate the carrying value of long-lived assets to be held and used when events and circumstances indicate that the carrying amount of an asset may not 2021 $21,000 not 2020. |
Derivatives, Policy [Policy Text Block] | Derivative Financial Instruments We may may not We recognize any unrealized gains and losses associated with derivative instruments accounted for as cash flow hedges in income in the period in which the underlying hedged transaction is realized. To the extent the derivative instrument is deemed ineffective we would recognize the resulting gain or loss in income at that time. As of June 30, 2021, June 30, 2021, $60.4 €51.3 14 As of June 30, 2021, not June 30, 2021, not $6.2 5.5 first 2022. |
Pension and Other Postretirement Plans, Policy [Policy Text Block] | Defined Benefit Pension Plan We formerly sponsored a defined benefit pension plan. Effective June 21, 1999, third |
Revenue [Policy Text Block] | Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that each of our performance obligations is fulfilled, and control of the ordered products is transferred to the customer. This transfer occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. We require prepayment from certain customers. We record any payments received in advance of contracts fulfillment as a contract liability and classified as customer deposits on the consolidated balance sheet. Except for product defects, no June 30, 2021, no We have an Exclusive Manufacturing Agreement with The Juice Plus+ Company LLC (“Juice Plus+”) through August 6, 2025. 24 $1.6 June 30, 2021, $1.6 June 30, 2020, We currently own certain U.S. patents, and each patent's corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine marketed and sold under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $14.2 2021 $12.6 2020. $0.6 2021 $0.5 2020. |
Cost of Goods and Service [Policy Text Block] | Cost of Goods Sold Cost of goods sold includes raw material, labor, manufacturing overhead, and royalty expense. |
Shipping and Handling Costs [Policy Text Block] | Shipping and Handling Costs We include fees earned on the shipment of our products to customers in sales and include costs incurred on the shipment of product to customers in costs of goods sold. |
Research and Development Expense, Policy [Policy Text Block] | Research and Development Costs As part of the services we provide to our private-label contract manufacturing customers, we may not not Research and development costs are expensed when incurred. Our research and development expenses for the last two June 30 $1.9 2021 $1.8 2020. |
Advertising Cost [Policy Text Block] | Advertising Costs We expense the production costs of advertising the first $0.8 June 30, 2021 $1.4 2020. |
Income Tax, Policy [Policy Text Block] | Income Taxes The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 2015 2016 may On July 23, 2020, September 21, 2020 may 18.9%. 18.9% June 30, 2020. 2020 June 30, 2021 2020 $0.4 2020 2015 2016, $0.3 June 30, 2021. June 30, 2021 $0.1 To determine our quarterly provision for income taxes, we use an estimated annual effective tax rate that is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions to which we are subject. Certain significant or unusual items are separately recognized as discrete items in the quarter in which they occur and can be a source of variability in the effective tax rate from quarter to quarter. We recognize interest and penalties related to uncertain tax positions, if any, as an income tax expense. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are measured and recorded using enacted tax rates for each of the jurisdictions in which we operate, and adjusted using the tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income or expense in the period that includes the enactment date. We account for uncertain tax positions using the more-likely-than- not may June 30, 2021 June 30, 2020, not We record valuation allowances to reduce our deferred tax assets to an amount that we believe is more likely than not not June 30, 2021, no |
Share-based Payment Arrangement [Policy Text Block] | Stock-Based Compensation We had an omnibus equity incentive plan that was approved by our Board of Directors effective October 15, 2009 November 30, 2009 "2009 2009 October 15, 2019. January 1, 2021 ( “2020 December 4, 2020. 2020 may We estimate the fair value of stock option awards at the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no not We recognize forfeitures as they occur. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates Our management has made a number of estimates and assumptions relating to the reporting of assets and liabilities, revenue and expenses, and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements in conformity with U.S. generally accepted accounting principles (GAAP). Actual results could differ from those estimates and our assumptions may |
Earnings Per Share, Policy [Policy Text Block] | Net Income (Loss) per Common Share We compute basic net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options and restricted shares account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): For the Years Ended June 30, 2021 2020 Numerator Net income (loss) $ 10,768 $ (1,645 ) Denominator Basic weighted average common shares outstanding 6,291 6,695 Dilutive effect of stock options and restricted stock shares 88 — Diluted weighted average common shares outstanding 6,379 6,695 Basic net income (loss) per common share $ 1.71 $ (0.25 ) Diluted net income (loss) per common share $ 1.69 $ (0.25 ) During the year ended June 30, 2021, 22,500 52,108 In periods where we have a net loss, stock options and restricted stock are excluded from our calculation of diluted net income (loss) per common share, as their inclusion would have an antidilutive effect. For the year ended June 30, 2020 130,000 323,904. |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentrations of Credit Risk Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly rated financial institutions. Credit risk with respect to receivables is primarily concentrated with our two 64.8% June 30, 2021 65.7% June 30, 2020. June 30, 2021, $3.5 June 30, 2020 $3.3 100% not Additionally, amounts due related to our beta-alanine raw material sales were 8.6% June 30, 2021 2.5% June 30, 2020. |